Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GPPAD-POInT primary oral insulin trial
2017-003088-36Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Oral insulin with Placebo (2 arms). Primary endpoint: Treatment duration until age 3 years or diabetes onset. Started Oct 2017; status: completed.
02
Drugs
regular human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2017-003088-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003088-36.